A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT06935370 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4200

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: vicadrostat
DRUG: empagliflozin
DRUG: Placebo

Sponsor

Boehringer Ingelheim